Laryn Rajkarnikar
Psychiatric/Mental Health · Irwin, PANPI 1982148284
Payments from drug & device makers
Across 242 payments — averaging $19.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Viiv Healthcare Company$688
- Otsuka America Pharmaceutical, Inc.$407
- Alkermes, Inc.$301
- Teva Pharmaceuticals USA, Inc.$256
- Corium, LLC$245
- plus $1K from 20 others
What the payments were for
- Food & beverage$4,60897%
- Education$1233%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 71 | $1,446 |
| Viiv Healthcare Company | 30 | $688 |
| Otsuka America Pharmaceutical, Inc. | 28 | $407 |
| Alkermes, Inc. | 14 | $301 |
| Teva Pharmaceuticals USA, Inc. | 15 | $256 |
| Corium, LLC | 14 | $245 |
| Lundbeck LLC | 11 | $192 |
| Johnson & Johnson(2 entities) | 7 | $160 |
| Vanda Pharmaceuticals Inc. | 7 | $152 |
| Axsome Therapeutics, Inc. | 6 | $143 |
| Neurocrine Biosciences, Inc. | 8 | $129 |
| Indivior Inc. | 5 | $107 |
| Merck | 5 | $100 |
| Idorsia Pharmaceuticals US Inc | 3 | $65 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $62 |
| Janssen Products, LP | 1 | $50 |
| Gilead | 3 | $42 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $38 |
| Hologic Sales And Service, LLC | 2 | $30 |
| Supernus Pharmaceuticals, Inc. | 1 | $22 |
| Braeburn Inc. | 1 | $18 |
| Antares Pharma, Inc. | 1 | $18 |
| Organon | 1 | $16 |
| Noven Therapeutics, LLC | 1 | $15 |
| Tris Pharma Inc | 1 | $14 |
| Theratechnologies Inc. | 1 | $14 |
How this compares
$4,731 in reported general payments places this provider in the 90th percentile of 1,041 psychiatric/mental health providers in Pennsylvania.
See all psychiatric/mental health providers in Pennsylvania →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lurasidone Hcl | 21 | $6,787 |
| Acamprosate Calcium | 12 | $1,634 |
| Prazosin Hcl | 39 | $635 |
| Duloxetine Hcl | 37 | $495 |
| Bupropion XlBupropion Hcl | 18 | $426 |
| Hydroxyzine Hcl | 14 | $335 |
| Guanfacine Hcl ErGuanfacine Hcl | 15 | $301 |
| Buspirone Hcl | 27 | $271 |
| Fluoxetine Hcl | 19 | $261 |
| Lamotrigine | 25 | $239 |
| Risperidone | 26 | $233 |
| Trazodone Hcl | 43 | $224 |
| Lorazepam | 24 | $204 |
| Escitalopram Oxalate | 28 | $190 |
| Mirtazapine | 13 | $124 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Irwin
- Kimberly GarciaAllentown$573K
- Cortney SmithWashington$227K
- Britney KeplerPittsburgh$158K
- Kirstyn KamegBethel Park$136K
- Anna DipietroDowningtown$131K
- Deena MasciocchiLanghorne$71K
- Joseph GagnonChesterbrook$64K
- Michelle CohenWashington$62K
- Sharon KatzJenkintown$51K
- Jennifer BowmanCanonsburg$48K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.